K. P. Croome, D. D. Lee, A. P. Keaveny, and C. B. Taner, Noneligible Donors as a Strategy to Decrease the Organ Shortage, American Journal of Transplantation, vol.17, pp.1649-1655, 2017.

R. W. Busuttil and K. Tanaka, The utility of marginal donors in liver transplantation, Liver Transplantation, vol.9, pp.651-663, 2003.

F. M. Dimou, The role of extended criteria donors in liver transplantation for nonalcoholic steatohepatitis, Surgery, vol.160, pp.1533-1543, 2016.

B. Nemes, Extended criteria donors in liver transplantation Part I: reviewing the impact of determining factors, Expert Rev. Gastroenterol. Hepatol, vol.10, pp.827-839, 2016.

B. Nemes, Extended-criteria donors in liver transplantation Part II: reviewing the impact of extended-criteria donors on the complications and outcomes of liver transplantation, Expert Rev. Gastroenterol. Hepatol, vol.10, pp.841-859, 2016.

I. Vodkin and A. Kuo, Extended Criteria Donors in Liver Transplantation, Clinics in Liver Disease, vol.21, pp.289-301, 2017.

S. Feng, Characteristics associated with liver graft failure: the concept of a donor risk index, American Journal of Transplantation, vol.6, pp.783-790, 2006.

A. Winter, External validation of the Donor Risk Index and the Eurotransplant Donor Risk Index on the French liver transplantation registry, Liver International, vol.37, pp.1229-1238, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01897350

A. Braat, The Eurotransplant Donor Risk Index in Liver Transplantation: ET-DRI, American Journal of Transplantation, vol.12, pp.2789-2796, 2012.

P. Royston and D. G. Altman, External validation of a Cox prognostic model: principles and methods, BMC Medical Research Methodology, vol.13, p.33, 2013.

A. Winter, A Donor Quality Index for liver transplantation: development, internal and external validation, Scientific Reports, 2018.

C. Jacquelinet, Les nouvelles règles d'attribution des greffons en transplantation hépatique. Le Courrier de la Transplantation VII, pp.215-221, 2007.

P. S. Kamath, A model to predict survival in patients with end-stage liver disease, Hepatology, vol.33, pp.464-470, 2001.

D. Schaubel, C. Sima, N. Goodrich, S. Feng, and R. Merion, The survival benefit of deceased donor liver transplantation as a function of candidate disease severity and donor quality, American Journal of Transplantation, vol.8, pp.419-425, 2008.

D. E. Schaubel, R. A. Wolfe, and F. K. Port, A Sequential Stratification Method for Estimating the Effect of a Time-Dependent Experimental Treatment in Observational Studies, Biometrics, vol.62, pp.910-917, 2006.

, Scientific RepoRtS |, vol.10, p.4111, 2020.

D. E. Schaubel and J. D. Kalbfleisch, Assessing the Effect on Survival of Kidney Transplantation with Higher-Risk Donor Kidneys, Statistics in Action: A Canadian Outlook, pp.209-224, 2014.

D. E. Schaubel, R. A. Wolfe, C. S. Sima, and R. M. Merion, Estimating the Effect of a Time-Dependent Treatment by Levels of an Internal Time-Dependent Covariate: Application to the Contrast Between Liver Wait-List and Posttransplant Mortality, Journal of the American Statistical Association, vol.104, pp.49-59, 2009.

, AJCC Cancer Staging Manual, 2017.

C. Francoz, Model for end-stage liver disease exceptions in the context of the french model for end-stage liver disease scorebased liver allocation system, Liver Transplantation, vol.17, pp.1137-1151, 2011.

Q. Lai, Intention-to-treat survival benefit of liver transplantation in patients with hepatocellular cancer, Hepatology, vol.66, pp.1910-1919, 2017.

S. Kitai, Survival Benefit of Locoregional Treatment for Hepatocellular Carcinoma with Advanced Liver Cirrhosis, Liver Cancer, vol.5, pp.175-189, 2016.

K. Berry and G. N. Ioannou, Comparison of Liver Transplant-Related Survival Benefit in Patients With Versus Without Hepatocellular Carcinoma in the United States, Gastroenterology, vol.149, pp.669-680, 2015.

A. Winter, J. Daurès, and P. Landais, Intention-to-treat survival benefit in liver transplantation, Hepatology, vol.67, pp.1638-1639, 2018.
URL : https://hal.archives-ouvertes.fr/hal-01741877

V. Mazzaferro, Liver Transplantation for the Treatment of Small Hepatocellular Carcinomas in Patients with Cirrhosis, N. Engl. J. Med, vol.334, pp.693-700, 1996.

D. S. Goldberg and K. M. Olthoff, Standardizing MELD Exceptions: Current Challenges and Future Directions, Current Transplantation Reports, vol.1, pp.232-237, 2014.

D. Goldberg, T. Bittermann, and G. Makar, Lack of Standardization in Exception Points for Patients With Primary Sclerosing Cholangitis and Bacterial Cholangitis: Exception Points for PSC, American Journal of Transplantation, vol.12, pp.1603-1609, 2012.

D. S. Goldberg, G. Makar, T. Bittermann, and B. French, Center variation in the use of nonstandardized model for end-stage liver disease exception points, Liver Transplantation, vol.19, pp.1330-1342, 2013.

R. B. Freeman, Model for end-stage liver disease (MELD) exception guidelines: Results and recommendations from the MELD exception study group and conference (MESSAGE) for the approval of patients who need liver transplantation with diseases not considered by the standard MELD formula, Liver Transplantation, vol.12, pp.128-136, 2006.

L. R. Callahan, Liver Review Board Guidance Documents, vol.38

D. Altman, Prognostic models: a methodological framework and review of models for breast cancer, Cancer Investigation, vol.27, pp.235-243, 2009.

D. Schaubel, Survival Benefit-Based Deceased-Donor Liver Allocation, American Journal of Transplantation, vol.9, pp.970-981, 2009.

, R Development Core Team. R: A Language and Environment for Statistical Computing. (R Foundation for Statistical Computing), 2008.